KARUNA THERAPEUTICS INC's ticker is KRTX and the CUSIP is 48576A100. A total of 147 filers reported holding KARUNA THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.63 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $23 | -23.3% | 138 | 0.0% | 0.00% | – |
| Q2 2023 | $30 | +20.0% | 138 | 0.0% | 0.00% | – |
| Q1 2023 | $25 | -7.4% | 138 | 0.0% | 0.00% | – |
| Q4 2022 | $27 | -99.9% | 138 | +13.1% | 0.00% | – |
| Q3 2022 | $27,000 | +92.9% | 122 | +9.9% | 0.00% | – |
| Q2 2022 | $14,000 | +27.3% | 111 | +29.1% | 0.00% | – |
| Q1 2022 | $11,000 | 0.0% | 86 | 0.0% | 0.00% | – |
| Q4 2021 | $11,000 | -8.3% | 86 | -14.9% | 0.00% | – |
| Q3 2021 | $12,000 | +100.0% | 101 | +87.0% | 0.00% | – |
| Q2 2021 | $6,000 | 0.0% | 54 | 0.0% | 0.00% | – |
| Q1 2021 | $6,000 | +20.0% | 54 | +8.0% | 0.00% | – |
| Q4 2020 | $5,000 | -54.5% | 50 | -66.0% | 0.00% | – |
| Q3 2020 | $11,000 | 0.0% | 147 | 0.0% | 0.00% | – |
| Q2 2020 | $11,000 | 0.0% | 147 | 0.0% | 0.00% | – |
| Q1 2020 | $11,000 | 0.0% | 147 | 0.0% | 0.00% | – |
| Q4 2019 | $11,000 | – | 147 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Pivotal bioVenture Partners Investment Advisor LLC | 782,008 | $142,043,933 | 58.49% |
| Nan Fung Group Holdings Ltd | 225,688 | $40,993,968 | 27.90% |
| Sofinnova Investments, Inc. | 1,773,124 | $322,070,243 | 20.60% |
| Artia Global Partners LP | 88,831 | $16,135,263 | 5.96% |
| DAFNA Capital Management LLC | 78,573 | $14,272,000 | 4.28% |
| First Light Asset Management, LLC | 243,675 | $44,261,127 | 3.98% |
| CATALYST PRIVATE WEALTH, LLC | 21,837 | $3,966,473 | 2.74% |
| Sands Capital Ventures, LLC | 58,895 | $10,697,688 | 2.64% |
| ARCH Venture Management, LLC | 30,000 | $5,449,200 | 2.63% |
| Logos Global Management LP | 100,000 | $18,164,000 | 2.60% |